Skip to content
Search
Biotech Frontiers

The Next Wave of Innovation

Biotech stocks have struggled as a group, but the pace of drug discovery is accelerating. In this episode of “The Angle,” Sal Rais joins Jennifer Martin to explore how new ways of treating disease are improving human health and how breakthrough drugs can create value for some biotech innovators.

Listen Now

Active investing is suited to the challenging markets ahead

Passive investment strategies enjoyed a long period of growth in the era of low rates, ample liquidity, and low volatility that followed the global financial crisis. However, in the new world of higher rates, greater dispersion, and heightened volatility, the need for active investment strategies will increase.

Read Now

We put our clients at the center of our best thinking

Global Markets Weekly Update
Aug 2025 MARKET INSIGHTS

Global Markets Weekly Update

Binoculars showing a global view in focus
FIXED INCOME INSIGHTS

Ahead of the Curve

View All Insights

Our insights show you what’s ahead, what’s most important, and how our investment teams are responding now - so you have the full picture.

Visit Insights

Customize your insights and product subscriptions

Register or sign in as an institutional investor or consultant to tailor your preferences.

Events and On-Demand Webinars

Hear directly from our experts on timely themes and topics. 

Explore Events
An animated image with four individuals on a screen

202507-4687954

Download

Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel

Open

Share Class: Language of the document:
Open Cancel
Sign in to manage subscriptions for products, insights and email updates.
Sign in
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price (“TRP”) claims compliance with the Global Investment Performance Standards (GIPS®).

A complete list and description of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest